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first column on page 516, relating to Reference 43 is misleading.
The sentence reads:
‘‘At the same time however, Gal-1 is found overexpressed on the
stromal tissues of long term pancreatic cancer survivors [43], indi-
cating that the prognostic significance of Gal-1 expression is not
entirely clear’’.However, the authors would like to correct this as:
‘‘At the same time, Gal-1 is found underexpressed on the stromal
tissues of long term pancreatic cancer survivors [43], indicating
that the prognostic significance of Gal-1 expression is promising’’.
The authors would like to apologise for any inconvenience
caused.
